Pillstats
Rx only · Solution/ Drops · Ophthalmic

Ciprofloxacin Hydrochloride

Ciprofloxacin Hydrochloride

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)2551
US makers8 labelers
Packages17
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.533$1.07$1.60$2.13Dec 2025Apr 2026Jul 2026
$1.784
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
8
Active US suppliers
35%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

16K32K48K65K2025 Q12025 Q22025 Q32025 Q42026 Q1
39K
Rx · 2026 Q1
228K
Units dispensed
-30%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Asclemed USA, Inc.unknown3SUPPLYING
Sandoz Incunknown3SUPPLYING
NuCare Pharmaceuticals, Inc.unknown3SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
Redpharm Drugunknown2SUPPLYING
Proficient Rx LPunknown2SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
Preferred Pharmaceuticals Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 13, 2022
    RECALLRecall (Class II): Ciprofloxacin Ophthalmic Solution 0.3%, 5 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 61314-656-05

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.